Search results
Results From The WOW.Com Content Network
The falling share price has pushed the stock's dividend yield to nearly 6%. There are signs though that the reduced-performance pain may be nearing an end. Catalysts in the drug production ...
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
Stock market investors have plenty of reasons to celebrate as 2024 comes to a close. The S&P 500 index set multiple new record highs during the year, delivering a spectacular 25% return year to ...
With a lot of new drugs to sell, Pfizer expects adjusted earnings to reach a range between $2.15 and $2.35 per share this year, which is more than it needs to meet a dividend commitment currently ...
For instance, if the record date is Sunday, then the ex-dividend date is the preceding Thursday, not Friday — assuming no intervening holidays. To be a stockholder on the record date, an investor must purchase the stock before the ex-dividend date in order to allow for the 1-trading day settlement of the stock purchase. If the investor ...
Pfizer's 5.7% dividend yield, while attractive, raises significant sustainability concerns. The company's payout ratio has skyrocketed to 436%, far exceeding the 75% threshold that typically ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut ...
A high-yield dividend stock with long-term potential Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable ...